One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men (MSM) in LA County over the next 10 years, cautions ...
Mar 18, 2013
0
0
(Medical Xpress)—Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary ...
Mar 14, 2013
0
0
Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according ...
Mar 1, 2013
0
0
An analysis of policy documents from Medicaid programs, suggests that current policies to manage conflicts of interest (COIs) of members of Medicaid drug selection committees are not transparent and vary widely, according ...
Feb 11, 2013
0
0
Doctors who graduate from medical schools with an active policy on restricting gifts from the pharmaceutical industry are less likely to prescribe new drugs over existing alternatives, suggests a study published in BMJ today.
Jan 31, 2013
0
0
More than a third of U.S. physicians responding to a national survey indicated they often or sometimes prescribed brand-name drugs when appropriate generic substitutes were available simply because patients requested the ...
Jan 7, 2013
1
0
"Understanding peoples' attitudes about whether states of being should be considered diseases can inform social discourse regarding a number of contentious social and health public policy issues," says Kari Tikkinen, MD, ...
Dec 3, 2012
0
0
More people are better off thanks to the impact of an influx of direct-to-consumer advertising spending than they would be without those marketing efforts, according to a study recently published by Jayani Jayawardhana, an ...
Nov 26, 2012
0
0
A Queen's University study of two eye drugs used to treat wet Age-related Macular Degeneration (AMD) has determined the cheaper of the two could lead to eye inflammation, a potentially blinding adverse effect.
Jun 18, 2012
0
0
Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts in the British Medical Journal today.
Mar 22, 2012
0
0
